prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - antígenos de superficie del virus de la gripe (hemaglutinina y neuraminidasa) de la cepa a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacunas - inmunización activa contra el subtipo h5n1 del virus influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
patanol solucion oftalmica esteril
novartis biociencias s.a [br] brazil - clorhidrato de oloptadina* 1,11mg *equivalente a 1mg de base - soluciÓn oftÁlmica - cada mililitro contiene: clorhidrato de oloptadina* 1,11 mg *equivalente a 1mg de base
naphcon a solucion oftalmica esteril
novartis biociencias s.a. [br] brazil - clorhidrato de nafazolina 0.25 mg maleato de feniramina 3.00 mg - solucion oftalmica - cada mililitro contiene: clorhidrato de nafazolina------------------------------------0.25 mg maleato de feniramina-----------------------------------------3.00 mg
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptina, metformin hidrocloruro - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).
azopt suspension oftalmica esteril
novartis pharma ag [ch] switzerland - brinzolamida 10 mg - suspension oftalmica esteril - cada mililitro contiene: brinzolamida 10 mg
aflarex(mr) acetato de fluormetolona 0,1% suspension ofatlmica esteril
novartis pharma ag [ch] switzerland - acetato de fluorometolona micronizada 1.0 mg - suspension oftalmica - cada mililitro contiene: acetato de fluorometolona micronizada 1.0 mg
tobrex solucion oftalmica esteril
novartis pharma ag [ch] switzerland - tobramicina 3,00 mg - solucion - cada ml contiene: tobramicina 3,00 mg
vigadexa solucion oftalmica
novartis pharma ag [ch] switzerland - moxifloxacino 5,00 mg/ml dexametasona 1,00 mg/ml - solución oftálmica - cada ml contiene: clorhidrato de moxifloxacino 5,45 mg (equivalente a 5,00 mg de la base) fosfato disódico de dexametasona 1,10 mg (equivalente a 1,00 mg de fosfato de dexametasona)
maxitrol mr suspension oftalmica esteril
novartis pharma ag [ch] switzerland - dexametasona 1.0 mg neomicina 3.5 mg polimixina b 6000 ui - suspension oftalmica - cada mililitro contiene: dexametasona 1.00 mg sulfato de neomicina* 5.00 mg equivalente a 3.5 mg de la base sulfato de polimixina b 6000 ui
tobradex suspension oftalmica esteril
novartis pharma ag [ch] switzerland - tobramicina 3,00 mg dexametasona 1,00 mg - suspensión oftálmica - cada mililitro contiene: tobramicina 3,00 mg dexametasona 1,00 mg